1-30874359-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_014654.4(SDC3):c.1100C>T(p.Ser367Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000508 in 1,613,774 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000050 ( 1 hom. )
Consequence
SDC3
NM_014654.4 missense
NM_014654.4 missense
Scores
4
15
Clinical Significance
Conservation
PhyloP100: 4.77
Genes affected
SDC3 (HGNC:10660): (syndecan 3) The protein encoded by this gene belongs to the syndecan proteoglycan family. It may play a role in the organization of cell shape by affecting the actin cytoskeleton, possibly by transferring signals from the cell surface in a sugar-dependent mechanism. Allelic variants of this gene have been associated with obesity. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM1
In a glycosylation_site O-linked (Xyl...) (glycosaminoglycan) serine (size 0) in uniprot entity SDC3_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.03531176).
BS2
High AC in GnomAd4 at 9 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDC3 | NM_014654.4 | c.1100C>T | p.Ser367Leu | missense_variant | 4/5 | ENST00000339394.7 | NP_055469.3 | |
SDC3 | XM_011542463.1 | c.1067C>T | p.Ser356Leu | missense_variant | 4/5 | XP_011540765.1 | ||
SDC3 | XM_011542464.3 | c.1064C>T | p.Ser355Leu | missense_variant | 4/5 | XP_011540766.1 | ||
SDC3 | XM_011542466.2 | c.974C>T | p.Ser325Leu | missense_variant | 4/5 | XP_011540768.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDC3 | ENST00000339394.7 | c.1100C>T | p.Ser367Leu | missense_variant | 4/5 | 1 | NM_014654.4 | ENSP00000344468.6 | ||
SDC3 | ENST00000336798.11 | c.926C>T | p.Ser309Leu | missense_variant | 2/3 | 1 | ENSP00000338346.7 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152162Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000959 AC: 24AN: 250322Hom.: 1 AF XY: 0.000155 AC XY: 21AN XY: 135432
GnomAD3 exomes
AF:
AC:
24
AN:
250322
Hom.:
AF XY:
AC XY:
21
AN XY:
135432
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461494Hom.: 1 Cov.: 32 AF XY: 0.0000715 AC XY: 52AN XY: 727060
GnomAD4 exome
AF:
AC:
73
AN:
1461494
Hom.:
Cov.:
32
AF XY:
AC XY:
52
AN XY:
727060
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74460
GnomAD4 genome
AF:
AC:
9
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
16
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2023 | The c.1100C>T (p.S367L) alteration is located in exon 4 (coding exon 4) of the SDC3 gene. This alteration results from a C to T substitution at nucleotide position 1100, causing the serine (S) at amino acid position 367 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MVP
MPC
0.061
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at